Neutralization epitopes of the HIV-1 primary isolate DH012 (Q73520511)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Neutralization epitopes of the HIV-1 primary isolate DH012 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Chongbin Zhu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Thomas J Matthews

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Chin Ho Chen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

3301-3306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Neutralization of primary and T-cell line adapted isolates of human immunodeficiency virus type 1: role of V3-specific antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Antibody neutralization of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900218-4

7 January 2021

10.1016/S0264-410X(03)00218-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804861%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference